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Table: Correlations between STR methods and infarct size
Spearman
rank A vs B A vs C B vs C
STR p0.0007 p0.75 p0.06 p0.009
max STR p0.0026 p0.76 p0.10 p0.06
ST residual p0.0001 p0.28 p0.0001 p0.0001
max ST residual p0.0001 p0.005 p0.0001 p0.0003
new Q waves p0.0001 p0.0001 p0.0001 p0.056
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Background: The HEBE study is a multicenter trial, where 200 patients with large first
AMI treated with primary percutaneous coronary intervention were randomly assigned to
either intracoronary infusion of mononuclear bone marrow (BMMC) cells (n69),
mononuclear peripheral blood cells (PBMC) (n66), or standard therapy (n65). At 4
months, regional or global systolic myocardial function improved in all groups, with no
significant difference between groups. Here, we conducted a 2 year magnetic resonance
imaging (MRI) follow-up.
Methods: In addition to 3-5 days after AMI, 4 months, patients underwent MRI at 2 years
after myocardial infarction and mononuclear cell infusion. All MRI analyses were
performed in a core laboratory using a standardized protocol and blinded for treatment
assignment.
Results: The percentage of dysfunctional left ventricular (LV) segments that improved
during 2 years of follow-up, did not differ significantly between BMMC and control:
(45.026.3% in the BMMC group, and 52.322.6% in the control group (p0.14).
However, the percentage was significantly lower in the PBMC group, 42.520.7%,
p0.03. Furthermore, there was less increase in LVEDV for BMMC (3.516.9 mL/m2)
compared to control (11.219.8 mL/m2, p0.03). The 3 groups did not differ in changes
in LVESV, LV mass and had similar rates of clinical events.
Conclusions: Intracoronary infusion of PBMCs and BMMC following AMI does not
improve recovery of myocardial function in the HEBE trial at 2-years of follow-up. The
increase in LVEDV was lower in the BMMC group, suggesting a long-term beneficial
effect on adverse LV remodeling after AMI.
Bone
Marrow
Group
Peripheral
Blood Group
Control
Group
Bone
Marrow
vs.
control
Peripheral
Blood vs.
control
(n59) (n48) (n58) p-value p-value
Primary endpoint (%)
Dysfunctional
segments at baseline
53.319.6 57.519.6 56.218.4
Dysfunctional
segments that
improved during
follow-up
45.026.3 42.520.7 52.322.6 0.14 0.03
LV ejection fraction
(%)
Baseline 43.79.0 41.79.1 42.48.3
24 months 49.28.1 44.910.3 47.79.4
Change 4.28.6 3.08.3 4.08.6 0.58 0.33
LV end-diastolic
volume (mL/m2)
Baseline 97.314.0 98.015.4 100.016.9
24 months 99.920.2 108.028.1 110.328.3
Change 3.516.9 9.220.9 11.219.8 0.03 0.63
LV end-systolic
volume (mL/m2)
Baseline 55.414.5 57.815.9 58.115.1
24 months 51.817.4 61.326.4 59.123.8
Change 1.815.0 3.318.8 3.016.3 0.11 0.94
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Background: Recovery of stunned myocardium can occur within 1 month from the
onset of ST-elevation myocardial infarction (STEMI). We examined the predictors of
recovery from stunning in the INFUSE-AMI randomized trial.
Methods: INFUSE-AMI was a 22 factorial design trial in which patients with STEMI
and proximal or mid left anterior descending (LAD) coronary artery occlusion receiving
bivalirudin anticoagulation were randomized to (1) bolus intracoronary abciximab via the
ClearWay RX catheter vs. no abciximab and (2) manual aspiration with the Export
catheter vs. no aspiration. In a formal substudy MRI imaging at both 5 and 30 days was
performed in 174 patients. MRI analysis included 1) microvascular obstruction (MVO)
defined as a black area inside a zone of delayed enhancement, 2) infarction area, 3)
transmural extent of infarction, and 4) total stunning/remodelling score as a sum of
segmental functional change ()from 5 to 30 days (2marked recovery, 1mild
recovery, 0no change, 1worse).
Results: Overall, left ventricular ejection fraction (LVEF) increased by 2.37.0% from
5 to 30 days. Compared to pts with LVEFmedian (2.1%), pts with LVEFmedian
were older, more often female, and more often diabetic (Table). Both MVO as % of LV
mass and transmural extent of infarction trended lower in pts with better LV recovery.
Multivariable analysis indicated that the independent predictors of better LV recovery
were smaller % MVO (coefficient 0.53, p0.002) and female gender (coefficient 2.68,
p0.05).
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LVEF >
median
LVEF <
median p value
Age, y 61.111.2 57.711.4 0.06
Female, % 28 12.2 0.01
Diabetes Mellitus, % 11 4.9 0.15
Symptom onset to balloon
time, min
17264 16161 0.27
Final corrected TIMI frame
count
20.67.4 23.212.7 0.13
Final blush score 2 or 3, % 81.7 88.9 0.2
Relative ST segment
resolution, %
72.8 [42.3, 85.3] 72.8 [57.7, 88.0] 0.56
LVEF change from
baseline to follow-up, %
7.65.0 3.04.1 0.0001
Total stunning/remodeling
score
2.53.1 0.52.3 0.0001
5 day LVEF, % 45.49.6 49.19.2 0.01
30 day LVEF, % 52.910.8 46.18.9 0.0001
5 day presence of MVO 52.5% (42/80) 59.5% (47/79) 0.37
5 day MVO, % of LV mass 0.30 [0.00, 1.67] 1.22 [0.00, 3.57] 0.06
5 day infarction, % of LV
mass
21.1 [12.9, 29.2] 22.4 [12.9, 33.9] 0.28
5 day transmurality of
infarction, %
71.9 [61.4, 79.6] 74.7 [65.9, 83.8] 0.08
Conclusions: Smaller area of microvascular obstruction 5 days after primary PCI for
STEMI predicts better recovery of regional and global left ventricular function.
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Background: Cardioprotective effects of human atrial natriuretic peptide (hANP) in
patients with acute myocardial infarction (MI) have been suggested by randomized
clinical trials, however, no reports used surrogate endpoints offered by cardiac magnetic
resonance (CMR), the current gold standard imaging modality. We evaluated the effects
of hANP on left ventricular (LV) function in patients with reperfused acute MI using
CMR.
Methods: Forty-nine patients with first-time acute MI reperfused with percutaneous
coronary intervention were studied. Continuous intravenous infusion of hANP was
initiated before reperfusion therapy and continued for at least 2 days in 21 patients (hANP
group). The remaining 28 patients received no adjunctive pharmacological therapy (no
hANP group). CMR was performed at the acute phase and after 6 months (6M) to
evaluate infarct size, LV end-diastolic and end-systolic volume and LV ejection fraction
(EF).
Results: We observed no difference in age, gender, coronary risk factors, maximum
levels of creatine phosphokinase, time to reperfusion and baseline CMR parameters
between the 2 groups. However, at 6M, a significant improvement in LVEF in hANP
group was seen compared to no hANP group (baseline: 48.1  11.4% to 6M: 52.8 
10.6% vs. baseline: 49.9  13.6% to 6M: 50.0  10.7%; p  0.015).
Conclusions: These results assessed using CMR suggest that intravenous hANP infusion
can improve LV systolic function in patients with reperfused acute MI.
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Background: Percutaneous coronary intervention (PCI) with adoption of coronary stents
since 1994, is an established management for ST-segment elevation myocardial infarction
(STEMI) and has been known relatively safe and effective resulting in better acute
angiographic outcomes, reduction in the frequency of repeated stenosis or revasculariza-
tion with proper antiplatelet agents. However, stent itself is related with major adverse
cardiac events (MACE) depending on stent parameters such as length, diameter or
structure materials under various clinical circumstances. In cases of long lesion, implan-
tation of multiple stents is common in daily practice and the relationship between multiple
stent implantation and MACE in acute myocardial infarction (MI) is shown by a few
studies but data is lack in the setting of STEMI. The aim of this study is to compare
clinical outcomes between single and multiple-stent implanted groups in Korean patients
with STEMI undergoing primary PCI.
Methods: Using data from Korea Acute Myocardial Infarction Registry (KAMIR;
November 2005-January 2008), a total of 1,668 patients with STEMI who proven to have
single culprit vessel disease on primary PCI were enrolled in this study. The patients were
divided into two groups: single stent group (n1,391, 83.4%) and multiple stent group
(277, 16.6%).
Results: The primary outcome, one-year cumulative incidence rate of MACE defined as
composition of death, nonfatal MI, re-PCI or coronary artery bypass graft, was signifi-
cantly higher in the multiple stent group (10.4% versus 16.7%, p0.010), which was
mainly due to increased target lesion revascularization (3.9% versus 9.4%, p0.001). By
multivariate logistic regression analysis, multiple stent implantation was remained as a
prognostic factor for MACE (OR1.590, 95% CI: 1.028-2.459, p0.037). Cox-
proportional hazard model also showed implanted stent number is associated with MACE
significantly (HR1.900, 95% CI: 1.157-3.119, p0.011).
Conclusions: This study demonstrated that multiple stent implantation is associated with
increased one-year cumulative incidence rate of MACE and is a predictor for clinical
outcomes independent of stent length, diameter or type in Korean populations with
STEMI.
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Background: Primary coronary intervention (PCI) with thrombectomy seems to reduce
the thrombus burden measured with optical frequency domain imaging (OFDI), resulting
in a better stent expansion and less late malapposition, when compared to PCI without
thrombectomy.
Methods: In a prospective multi-centre study, 141 patients with STEMI12 hours from
onset were randomized to either PCI with thrombectomy (TB: n71) or without
thrombectomy (nonTB: n70), with blinding of the operator for the OFDI results. The
primary endpoint was minimal flow area (Min FA) post-procedure assessed by OFDI,
defined as: (Stent area	 incomplete stent apposition [ISA] area) – (intraluminal defect	
tissue prolapse area). Sample size was based on the expected difference of 0.72mm2 in
MinFA. Fifty-one patients repeated invasive angiographic and OFDI follow-up at 6
months.
Results: Baseline demographics, preprocedural QCA and procedural characteristics were
well matched between the two groups. Immediately after stenting on OFDI, the average
stent area, the amount of prolapse, intraluminal defect and ISA area were similar in the
both groups. In the population with a serial OFDI follow-up at Baseline and 6M, the
post-procedural minFA were numerically larger in TB than in non-TB, but the difference
did not reach statistical significance (TB 6.052.18 vs. 5.612.06 mm2, p031). At
6 months, the mean ISA area was similar between two groups (TB 0.020.06 vs. non-TB
0.020.04 mm2, p0.68). The percent coverage of struts was low but there were no
differences between the groups (TB 83.869.91% vs. non-TB 84.0414.72%).
Conclusions: At 6M follow-up, there were no differences in the mean ISA area as well
as %tissue coverage between the thrombectomy and non-thrombectomy group. Three-
dimensional presentation of intra-luminal masses at baseline and follow-up will be
presented at the meeting.
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Background: ST elevation myocardial infarction (STEMI) complicated by out of
hospital cardiac arrest (OOHCA) is associated with significant mortality. Small observa-
tional studies have shown survival benefit with primary percutaneous coronary interven-
tion (pPCI) in this setting. We sought to investigate morbidity and mortality outcomes in
this patient cohort.
Methods: Between January 2008 and October 2011, STEMI admissions to a regional
cardiac centre were retrospectively analysed. 122 patients with OOHCA in the context of
STEMI were identified. Clinical data was collected from the UK Myocardial Ischaemia
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